June 1, 2026: Wegovy and GLP-1 Litigation Grows to More Than 3,700 Plaintiffs and Novo Nordisk Asks for Cases to Be Dismissed As of June 1, 2026, there are 3,763 pending claims in the GLP-1 MDL, which includes plaintiffs alleging injuries from Wegovy
Its structure makes it suitable for receptor selectivity studies involving MC3R and MC4R
What Does Retatrutide Actually Treat
& Alves, P
Serious and Potential Long-Term Risks More serious potential adverse effects have also been reported, including: Pancreatitis: Inflammation of the pancreas, which can be life-threatening
/ Non-Surgical / Skin Care Products Medical-grade skin care products offer a variety of benefits for both women and men looking to achieve more radiant, youthful-looking skin